Company: IXHL
Filing Date: 2025-03-24
Form Type: S-3
Source: 0001013762-25-001587
Chunk: 30

Company: Incannex Healthcare Inc.
Filing Date: 2025-03-24
Form: S-3
Chunk 30
---
laws, our indemnification agreements with our
current directors and executive officers and Sections 102 and 145 of the DGCL is not intended to be exhaustive and is respectively qualified
in its entirety by such amended and restated certificate of incorporation, such amended and restated bylaws, such indemnification agreements
and such statutes.

To the extent that our directors,
officers and controlling persons are indemnified under the provisions contained in our amended and restated certificate of incorporation,
as amended, Delaware law or contractual arrangements against liabilities arising under the Securities Act, we have been advised that in
the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act
and is therefore unenforceable.

Item 16. Exhibits and Financial Statements Schedules.

| Exhibit Number 
 2.1            
 3.1            |     | Description                                                                                                                                                                                                                                                                                
 Deed of Amendment and Restatement to Scheme Implementation Deed, dated September 13, 2023, between Incannex Healthcare Limited and Incannex Healthcare Inc. (incorporated by reference to Exhibit 2.1 of the Company’s Current Report on Form 8-K filed with the SEC on November 29, 2023) 
 Amended and Restated Certificate of Incorporation, as filed with the Secretary of State of the State of Delaware on July 31, 2023 (incorporated by reference to Exhibit 3.1 of the Company’s Current Report on Form 8-K filed with the SEC on November 29, 2023)                           |
|:---------------|:----|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 3.2            |     | Amended and Restated Bylaws, dated November 20, 2023 (incorporated by reference to Exhibit 3.2 of the Company’s Current Report on Form 8-K filed with the SEC on November 29, 2023)                                                                                                        |
| 4.1            |     | Description of Securities (incorporated by reference to Exhibit 99.1 of the Company’s Current Report on Form 8-K filed with the SEC on November 29, 2023)                                                                                                                                  |
| 4.2            |     | Form of Series A Warrant (incorporated by reference to Exhibit 4.1 of the Company’s Current Report on Form 8-K filed with the SEC on March 10, 2025)                                                                                                                                       |
| 4.3            |